SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 1 — Judy Garland — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientJudy Garland
Date of birth1922-06-10
IdentifiersMRN HR-ML005-SYN-TD; SSN (made up) 000-05-6127
Document date1955-06-22
AuthorMargaret Ellsworth-Diaz, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Subjective

The patient attends this visit for establishing primary care for long-term prescribed sleeping pills and stimulants that began in adolescence: a nonjudgmental assessment, a prescription drug monitoring program review, sleep, mood, anxiety and safety, nutrition, and contraception three months after childbirth. [S]

Objective

Hemoglobin: 12.3 g/dL; MCV: 86 fL; Platelets: 284 10*3/uL; Ferritin: 24 ng/mL; Sodium: 139 mmol/L; Potassium: 4.1 mmol/L; Creatinine: 0.66 mg/dL; eGFR (CKD-EPI 1950): 119 mL/min/1.73 m²; Glucose: 82 mg/dL; AST: 21 U/L; ALT: 18 U/L; GGT: 24 U/L; TSH: 1.9 mIU/L; DAST-10: 6; AUDIT-C: 2; PHQ-9: 14; GAD-7: 13. [S]

Vital Signs

DateMeasureValueUnitProvenance
1955-06-22Body height151cmS
1955-06-22Body weight46.5kgS
1955-06-22Body mass index (BMI) [Ratio]20.4kg/m2S
1955-06-22Systolic blood pressure128mm[Hg]S
1955-06-22Diastolic blood pressure84mm[Hg]S
1955-06-22Heart rate98/minS
1955-06-22Respiratory rate16/minS
1955-06-22Body temperature36.8CelS
1955-06-22Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1955-06-22Hemoglobin [Mass/volume] in Blood12.3g/dL12-15.5 g/dLNormalS
1955-06-22MCV [Entitic mean volume] in Red Blood Cells by Automated count86fL80-100 fLNormalS
1955-06-22Platelets [#/volume] in Blood by Automated count28410*3/uL150-400 10*3/uLNormalS
1955-06-22Ferritin [Mass/volume] in Serum or Plasma24ng/mL15-150 ng/mLNormalS
1955-06-22Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
1955-06-22Potassium [Moles/volume] in Serum or Plasma4.1mmol/L3.5-5.1 mmol/LNormalS
1955-06-22Creatinine [Mass/volume] in Serum or Plasma0.66mg/dL0.59-1.04 mg/dLNormalS
1955-06-22Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1950)/1.73 sq M119mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1955-06-22Glucose [Mass/volume] in Serum or Plasma82mg/dL70-99 mg/dLNormalS
1955-06-22Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma21U/L10-35 U/LNormalS
1955-06-22Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma18U/L7-35 U/LNormalS
1955-06-22Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma24U/L5-40 U/LNormalS
1955-06-22Thyrotropin [Units/volume] in Serum or Plasma1.9m[IU]/L0.4-4.5 mIU/LNormalS
1955-06-22Total score [DAST-10]6{score}S
1955-06-22Total score [AUDIT-C]2{score}S
1955-06-22Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]14{score}S
1955-06-22Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]13{score}S

Medications

MedicationFrequencyRouteDatesStatusEvidence
Secobarbital 100 mg oral capsule, two capsules (200 mg) at bedtime; prescribed elsewhere for years; continued by this clinic at the verified dose, seven days at a time, until a supervised withdrawal is planned with addiction medicineTwo capsules at bedtime; no extra dosesOral route1955-06-22 to 1955-07-06completedS
Dextroamphetamine 10 mg oral tablet, one tablet each morning; no extra doses; prescribed elsewhere for weight and energyOne tablet each morningOral route1955-06-22 to 1955-07-20completedS
Sertraline 25 mg oral tablet, one tablet dailyOne tablet dailyOral route1955-06-22 to 1955-06-29completedS
Medroxyprogesterone acetate 150 mg/mL injection, 150 mg into the muscle every 13 weeks150 mg intramuscularly every 13 weeksIntramuscular route1955-06-22activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Problems

ProblemClinical statusVerificationCodeProvenance
Sedative, hypnotic, or anxiolytic use disorder (barbiturate), moderate, with physiological dependence; began with sleeping pills given in adolescence; synthetic modern episode linked to her documented lifelong dependence on prescribed sleeping pillsactiveconfirmed F13.20S — Synthetic modern coding. Tolerance and withdrawal are not counted toward the diagnosis for a medicine taken under medical supervision; five other criteria are met. Person-first language; not a claim about her real diagnosis.
Stimulant use disorder (prescribed amphetamine), mild; began with stimulants given in adolescence for weight and energy; synthetic modern episode linked to her documented pep pillsactiveconfirmed F15.10S — Synthetic modern coding; DSM-5-TR mild stimulant use disorder maps to F15.10. Tolerance and withdrawal are not counted for a supervised prescription.
Chronic insomnia disorder, long-standing, with sleep tied to sleeping pills since adolescenceactiveconfirmed G47.00S — Synthetic modern diagnosis anchored to the documented sleeping pills.
Contraception three months after childbirth while starting an enzyme-inducing drug: injectable progestin chosen because barbiturates, including any used for the withdrawal, weaken contraceptive pills, patches, rings and implantsactiveconfirmed Z30.013S — Synthetic contraception need; the birth is documented.
Major depressive disorder, single episode, moderate, with anxious distress; Mood Disorder Questionnaire negative and no history of mania or hypomaniaactiveconfirmed F32.1S — Synthetic modern diagnosis; not a claim about her real mood. The roster's bipolar disorder lead is not supported by the sources read and is not used.

Assessment

Plan of Treatment